Contezolid

Overview

Contezolid (MRX-I), a new and orally active oxazolidinone , is an antibiotic in study for complicated skin and soft tissue infections (cSSTI) caused by resistant Gram-positive bacteria. Contezolid (MRX-I) markedly reduces potential for myelosuppression and monoamine oxidase inhibition (MAOI).

Application

Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > Anti-infection | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Infection | Products > Signaling Pathways > Bacterial | Products > Signaling Pathways > Antibiotic | Products > Signaling Pathways > Monoamine Oxidase

Product Information

• Catalog No.: HY-19915
• CAS No.: 1112968-42-9
• Molecular Formula: C18H15F3N4O4
• Molecular Weight: 408.33
• Purity: 99.21%
• Storage: 4°C, sealed storage, away from moisture and light * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
• Solubility: ≥ 2.08 mg/mL (5.09 mM); Clear solution
• Availability: In-stock

Source

Original product source